Your browser doesn't support javascript.
loading
Clinical utility of a novel test for assessing cardiovascular disease risk in type 2 diabetes: a randomized controlled trial.
Peabody, John W; Paculdo, David; de Belen, Enrico; Ganesan, Divya; Cooney, Isabella; Trujillo, Nelson.
Affiliation
  • Peabody JW; QURE Healthcare, 450 Pacific Ave., Suite 200, San Francisco, CA, 94133, USA. jpeabody@qurehealthcare.com.
  • Paculdo D; University of California, San Francisco, 550 16th Street, Third Floor, San Francisco, CA, USA. jpeabody@qurehealthcare.com.
  • de Belen E; University of California, Los Angeles, 650 Charles E. Young Dr S, Los Angeles, CA, USA. jpeabody@qurehealthcare.com.
  • Ganesan D; QURE Healthcare, 450 Pacific Ave., Suite 200, San Francisco, CA, 94133, USA.
  • Cooney I; QURE Healthcare, 450 Pacific Ave., Suite 200, San Francisco, CA, 94133, USA.
  • Trujillo N; QURE Healthcare, 450 Pacific Ave., Suite 200, San Francisco, CA, 94133, USA.
Diabetol Metab Syndr ; 15(1): 155, 2023 Jul 13.
Article in En | MEDLINE | ID: mdl-37438853
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Aspects: Patient_preference Language: En Journal: Diabetol Metab Syndr Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Aspects: Patient_preference Language: En Journal: Diabetol Metab Syndr Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido